Ethosuximide
- Product NDC
- 0093-9660
- 11-digit product format
- 000939660
- Labeler code
- 0093
- Product ID
- 0093-9660_ef2b9689-f74f-4904-b9df-bab0cdef2e62
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ethosuximide
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA081306
- Marketing category
- ANDA
- Marketing start
- 1994-07-01
- Marketing end
- 2019-10-31
- Substance
- ETHOSUXIMIDE
- Active strength
- 250 mg/5mL
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status.
Dataset, Scope, Product NDC table| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|
| excluded product | product | 0093-9660 | | D | Discontinued by firm | | 2026-07-31 |
| excluded package | package | 0093-9660 | 0093-9660-16 | D | Discontinued by firm | | 2026-07-31 |
Orange Book products#
Application-product, Trade name, Ingredient table| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|
| A081306-001 | ETHOSUXIMIDE | ETHOSUXIMIDE | 250MG/5ML | SYRUP / ORAL | | | 1993-07-30 |
DailyMed Socrata Ingredients#